Digest

Ian Forgacs

Associate Editor

The first 150 words of the full text of this article appear below.

A few years ago I just about won a debate at the BSG opposing the motion that testing and treating for Helicobacter pylori was an acceptable strategy in primary care. How strongly I believed in the argument seemed irrelevant at the time. Yet the world moves on and more evidence accumulates. Delaney highlights a clinical @lert which suggests that test and treat followed by endoscopy for non-responders was less effective than incorporating a trial of a proton pump inhibitor (whether or not test and treat were incorporated into the treatment programme). Whether a tester, a treater, or an endoscopist do try a PPI. See page 10

A trick: to test and treat. See page 9.

The severity and progression of HCV infection varies between individuals. A number of host, viral, and environmental factors may be responsible for this difference. Alcohol is deleterious to the HCV infected liver but now . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Dyspepsia management in the millennium: to test and treat or not?

B C Delaney
Gut 2003 52: 10-11. [Extract] [Full Text] [PDF]

Impact of smoking on histological liver lesions in chronic hepatitis C

C Hézode, I Lonjon, F Roudot-Thoraval, J-P Mavier, J-M Pawlotsky, E S Zafrani, and D Dhumeaux
Gut 2003 52: 126-129. [Abstract] [Full Text] [PDF]

Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up

Z Mahmood, B P McMahon, Q Arfin, P J Byrne, J V Reynolds, E M Murphy, and D G Weir
Gut 2003 52: 34-39. [Abstract] [Full Text] [PDF]

Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up

H R Koelz, R Arnold, M Stolte, M Fischer, and A L Blum
Gut 2003 52: 40-46. [Abstract] [Full Text] [PDF]

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

W M Gonsalkorale, C Perrey, V Pravica, P J Whorwell, and I V Hutchinson
Gut 2003 52: 91-93. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Maunsell, Z., Wright, D. J., Rainbow, S. J. (2005). Routine Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Measurement of the 25-Hydroxy Metabolites of Vitamins D2 and D3. Clin. Chem. 51: 1683-1690 [Abstract] [Full Text]  
• Whelan, K., Judd, P. A., Preedy, V. R., Simmering, R., Jann, A., Taylor, M. A. (2005). Fructooligosaccharides and Fiber Partially Prevent the Alterations in Fecal Microbiota and Short-Chain Fatty Acid Concentrations Caused by Standard Enteral Formula in Healthy Humans. J. Nutr. 135: 1896-1902 [Abstract] [Full Text]  
• Oksanen, A, Sankila, A, von Boguslawski, K, Sipponen, P, Rautelin, H (2005). Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infection. J. Clin. Pathol. 58: 376-381 [Abstract] [Full Text]  
• Caturelli, E, Solmi, L, Anti, M, Fusilli, S, Roselli, P, Andriulli, A, Fornari, F, Del Vecchio Blanco, C, de Sio, I (2004). Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 53: 1356-1362 [Abstract] [Full Text]  
• Levi, E, Klimstra, D S, Adsay, N V, Andea, A, Basturk, O (2004). MUC1 and MUC2 in pancreatic neoplasia. J. Clin. Pathol. 57: 456-462 [Abstract] [Full Text]